# The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

> **NCT06222164** · — · RECRUITING · sponsor: **Invivoscribe, Inc.** · enrollment: 2000 (estimated)

## Conditions studied

- Hematologic Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06222164
- **Lead sponsor:** Invivoscribe, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-30
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06222164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06222164, "The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06222164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*